BioVersys extends its series C round to CHF 32.6 Million
05.01.2023
BioVersys AG announces extension of its Series C investment round to CHF 32.6 million as the AMR Action Fund makes its first European-based investment...
News
New Tech Park Basel CEO selected
26.10.2022
We are pleased to announce that Christian Harr (current COO) will become the new CEO of Tech Park Basel. He will take up the new position on...
Industry Night 2022: Tech Park Basel draws a positive conclusion
23.09.2022
Impressive first edition: The Regio Basel 2022 Industry Night was also a great success at Tech Park Basel. 44 companies from Basel and the region opened their ...
Kinarus announces the issuance of convertible notes
22.08.2022
Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville...
Versant Ventures Launches Vector BioPharma AG
10.08.2022
Versant has made a $30 million Series A commitment to Vector, which is the most recent company to be launched out of the ...